Summary:
A randomized, Double-blind, Placebo Controlled, Phase 3 Trial to evaluate the efficacy and Safety of Study Drug for the treatment of Moderate to Severe Vasomotor symptoms in Postmenopausal Women.
Qualified Participants Must:
• Postmenopausal women
• 40 -65 years of age seeking treatment for relief of moderate to severe vasomotor symptoms (hot flashes)
• able and willing to complete daily paper diaries
• Be willing to have an endometiral biopsy
• English or Spanish speaking
Qualified Participants May Receive:
Study medication and evaluations by board certified physicians and study coordinators; Compensation for time and travel